Literature DB >> 33273733

The global chimeric antigen receptor T (CAR-T) cell therapy patent landscape.

Liyang Lyu1, Ye Feng1, Xin Chen1, Yuanjia Hu2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33273733     DOI： 10.1038/s41587-020-00749-8

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  5 in total

1.  CAR-based cell therapy: evaluation with bibliometrics and patent analysis.

Authors:  Yajun Yuan; Qihan Fu; Yaqun Zhang; Danhai Xu; Yeqing Wu; Qiufei Qiu; Wuyuan Zhou
Journal:  Hum Vaccin Immunother       Date:  2021-06-29       Impact factor: 4.526

2.  Delivery of therapeutic small interfering RNA: The current patent-based landscape.

Authors:  Yu Chen; Shi-Hang Xiong; Fei Li; Xiang-Jun Kong; De-Fang Ouyang; Ying Zheng; Hua Yu; Yuan-Jia Hu
Journal:  Mol Ther Nucleic Acids       Date:  2022-06-22       Impact factor: 10.183

3.  A cell-based phenotypic library selection and screening approach for the de novo discovery of novel functional chimeric antigen receptors.

Authors:  Julie K Fierle; Johan Abram-Saliba; Vasileios Atsaves; Matteo Brioschi; Mariastella de Tiani; Patrick Reichenbach; Melita Irving; George Coukos; Steven M Dunn
Journal:  Sci Rep       Date:  2022-01-21       Impact factor: 4.379

Review 4.  Emerging Novel Combined CAR-T Cell Therapies.

Authors:  Anh Nguyen; Gary Johanning; Yihui Shi
Journal:  Cancers (Basel)       Date:  2022-03-09       Impact factor: 6.639

5.  Characteristics of Registered Studies of Chimeric Antigen Receptor Therapies: A Systematic Review.

Authors:  Rahul Banerjee; Vinay Prasad
Journal:  JAMA Netw Open       Date:  2021-07-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.